INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 172 filers reported holding INTERSECT ENT INC in Q1 2018. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $40,000 | -31.0% | 1,341 | -36.7% | 0.00% | – |
| Q4 2021 | $58,000 | 0.0% | 2,120 | 0.0% | 0.00% | – |
| Q3 2021 | $58,000 | +61.1% | 2,120 | 0.0% | 0.00% | – |
| Q2 2021 | $36,000 | -18.2% | 2,120 | 0.0% | 0.00% | – |
| Q1 2021 | $44,000 | -8.3% | 2,120 | 0.0% | 0.00% | – |
| Q4 2020 | $48,000 | +37.1% | 2,120 | 0.0% | 0.00% | – |
| Q3 2020 | $35,000 | +25.0% | 2,120 | 0.0% | 0.00% | – |
| Q2 2020 | $28,000 | +12.0% | 2,120 | 0.0% | 0.00% | – |
| Q1 2020 | $25,000 | -51.9% | 2,120 | 0.0% | 0.00% | – |
| Q4 2019 | $52,000 | -42.9% | 2,120 | -46.9% | 0.00% | – |
| Q2 2019 | $91,000 | -28.9% | 3,995 | 0.0% | 0.00% | – |
| Q1 2019 | $128,000 | +17.4% | 3,995 | 0.0% | 0.00% | – |
| Q4 2018 | $109,000 | -5.2% | 3,995 | 0.0% | 0.00% | – |
| Q3 2018 | $115,000 | -22.8% | 3,995 | 0.0% | 0.00% | – |
| Q2 2018 | $149,000 | -5.1% | 3,995 | 0.0% | 0.00% | – |
| Q1 2018 | $157,000 | +21.7% | 3,995 | 0.0% | 0.00% | – |
| Q4 2017 | $129,000 | +11.2% | 3,995 | 0.0% | 0.00% | – |
| Q3 2017 | $116,000 | – | 3,995 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KOPP INVESTMENT ADVISORS LLC | 238,698 | $3,781,000 | 3.74% |
| PURA VIDA INVESTMENTS, LLC | 275,000 | $4,356,000 | 1.32% |
| Broadfin Capital, LLC | 638,600 | $10,115,000 | 0.91% |
| Aisling Capital LLC | 248,498 | $3,936,000 | 0.81% |
| Bellevue Group AG | 205,325 | $3,252,000 | 0.59% |
| Iguana Healthcare Management, LLC | 180,000 | $2,852,000 | 0.51% |
| Rock Springs Capital Management LP | 345,000 | $5,465,000 | 0.34% |
| SECTORAL ASSET MANAGEMENT INC | 168,140 | $2,663,000 | 0.26% |
| FORMULA GROWTH LTD | 62,213 | $985,000 | 0.22% |
| MENTA CAPITAL LLC | 111,915 | $1,773,000 | 0.17% |